Page last updated: 2024-09-03

omega-n-methylarginine and Peripheral Vascular Diseases

omega-n-methylarginine has been researched along with Peripheral Vascular Diseases in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	3 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Beckman, JA; Conte, MS; Gerhard-Herman, M; Owens, CD; Wake, N	1
Cannon, RO; Gladwin, MT; Levin, IW; Zuzak, KJ	1
Ferlitsch, A; Kapiotis, S; MacAllister, RJ; Marsik, C; Mittermayer, F; Pleiner, J; Schaller, G; Wolzt, M; Ziegler, S	1

Trials

2 trial(s) available for omega-n-methylarginine and Peripheral Vascular Diseases

Article	Year
Imaging hemoglobin oxygen saturation in sickle cell disease patients using noninvasive visible reflectance hyperspectral techniques: effects of nitric oxide. American journal of physiology. Heart and circulatory physiology, 2003, Volume: 285, Issue:3 Topics: Acetylcholine; Adolescent; Adult; Anemia, Sickle Cell; Blood Gas Monitoring, Transcutaneous; Enzyme Inhibitors; Female; Hand; Hemoglobin, Sickle; Humans; Male; Middle Aged; Nitric Oxide; omega-N-Methylarginine; Oxyhemoglobins; Peripheral Vascular Diseases; Regional Blood Flow; Skin; Vasodilator Agents	2003
Intra-arterial vitamin C prevents endothelial dysfunction caused by ischemia-reperfusion. Atherosclerosis, 2008, Volume: 197, Issue:1 Topics: Adult; Antioxidants; Ascorbic Acid; Endothelium, Vascular; Enzyme Inhibitors; Forearm; Humans; Injections, Intra-Arterial; Male; Middle Aged; omega-N-Methylarginine; Oxidative Stress; Peripheral Vascular Diseases; Plethysmography; Regional Blood Flow; Reperfusion Injury; Vasodilation	2008

Article

Year

Imaging hemoglobin oxygen saturation in sickle cell disease patients using noninvasive visible reflectance hyperspectral techniques: effects of nitric oxide.

American journal of physiology. Heart and circulatory physiology, 2003, Volume: 285, Issue:3

Topics: Acetylcholine; Adolescent; Adult; Anemia, Sickle Cell; Blood Gas Monitoring, Transcutaneous; Enzyme Inhibitors; Female; Hand; Hemoglobin, Sickle; Humans; Male; Middle Aged; Nitric Oxide; omega-N-Methylarginine; Oxyhemoglobins; Peripheral Vascular Diseases; Regional Blood Flow; Skin; Vasodilator Agents

2003

Intra-arterial vitamin C prevents endothelial dysfunction caused by ischemia-reperfusion.

Atherosclerosis, 2008, Volume: 197, Issue:1

Topics: Adult; Antioxidants; Ascorbic Acid; Endothelium, Vascular; Enzyme Inhibitors; Forearm; Humans; Injections, Intra-Arterial; Male; Middle Aged; omega-N-Methylarginine; Oxidative Stress; Peripheral Vascular Diseases; Plethysmography; Regional Blood Flow; Reperfusion Injury; Vasodilation

2008

Other Studies

1 other study(ies) available for omega-n-methylarginine and Peripheral Vascular Diseases

Article	Year
In vivo human lower extremity saphenous vein bypass grafts manifest flow mediated vasodilation. Journal of vascular surgery, 2009, Volume: 50, Issue:5 Topics: Administration, Oral; Brachial Artery; Cohort Studies; Endothelium, Vascular; Enzyme Inhibitors; Femoral Artery; Humans; Hyperemia; Infusions, Intravenous; Lower Extremity; Nitric Oxide; Nitric Oxide Synthase Type III; Nitroglycerin; omega-N-Methylarginine; Peripheral Vascular Diseases; Popliteal Artery; Regional Blood Flow; Saphenous Vein; Time Factors; Treatment Outcome; Ultrasonography, Doppler; Vascular Patency; Vasodilation; Vasodilator Agents	2009

Article

Year

In vivo human lower extremity saphenous vein bypass grafts manifest flow mediated vasodilation.

Journal of vascular surgery, 2009, Volume: 50, Issue:5

Topics: Administration, Oral; Brachial Artery; Cohort Studies; Endothelium, Vascular; Enzyme Inhibitors; Femoral Artery; Humans; Hyperemia; Infusions, Intravenous; Lower Extremity; Nitric Oxide; Nitric Oxide Synthase Type III; Nitroglycerin; omega-N-Methylarginine; Peripheral Vascular Diseases; Popliteal Artery; Regional Blood Flow; Saphenous Vein; Time Factors; Treatment Outcome; Ultrasonography, Doppler; Vascular Patency; Vasodilation; Vasodilator Agents

2009